China's veterinary biological products industry has experienced the government procurement of the "Golden Decade", ten years, sales growth in 2009 to 5.8 billion, the average annual growth rate of up to 22%! Since then, the market Miao began to cut a striking figure, and its permeability has a greater breakthrough, but the overall market to see the seedling penetration rate is still at a low level.

With the policy liberalization and raising the concentration of aquaculture, the market will accelerate the implementation of the vaccine will be forced to become the main force to drive the expansion of the industry. China's wide range of animal vaccine products, but biased in the pig and poultry seedlings, and the traditional vaccine-based. It is expected that the improvement of conventional vaccine from 2017, the development of new vaccine in the development of enterprises will be more important, become the main battlefield of business competition. The development of veterinary biological products industry mainly presents the following three trends: